Display options
Share it on

Science. 2021 Nov 09;eabl8506. doi: 10.1126/science.abl8506. Epub 2021 Nov 09.

Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants.

Science (New York, N.Y.)

Matthew McCallum, Alexandra C Walls, Kaitlin R Sprouse, John E Bowen, Laura E Rosen, Ha V Dang, Anna De Marco, Nicholas Franko, Sasha W Tilles, Jennifer Logue, Marcos C Miranda, Margaret Ahlrichs, Lauren Carter, Gyorgy Snell, Matteo Samuele Pizzuto, Helen Y Chu, Wesley C Van Voorhis, Davide Corti, David Veesler

Affiliations

  1. Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
  2. Vir Biotechnology, San Francisco, CA 94158, USA.
  3. Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.
  4. Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98195, USA.
  5. Center for Emerging and Re-emerging Infectious Diseases, Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.
  6. Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
  7. Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA.

PMID: 34751595 DOI: 10.1126/science.abl8506

Abstract

[Figure: see text].

Publication Types